Semler Scientific, Inc. (SMLR) faced a significant 13% plunge in its stock price during Friday's pre-market trading session, underperforming the broader market. The healthcare technology firm's shares took a hit following the announcement of an upsized $85 million convertible senior notes offering, raising concerns about potential equity dilution.
The company revealed plans to issue the convertible notes due 2030 in a private offering to institutional buyers. While the initial offering size was set at $75 million, strong demand prompted Semler Scientific to upsize the offering to $85 million, with an option to purchase an additional $15 million worth of notes.
Investors reacted negatively to the news, as convertible debt offerings often lead to the issuance of new shares when the notes are converted, diluting existing shareholders' stakes. Additionally, Semler Scientific stated its intention to use a portion of the proceeds to fund capped call transactions and acquire bitcoin as part of its bitcoin treasury strategy, further fueling concerns about the company's capital allocation decisions.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。